News

A look at surgical procedures in patients with carotid artery stenosis: The second asymptomatic carotid trial (ACST-2)

1500 1000 Akshar Patel

Carotid artery stenting (CAS) and carotid endarterectomy (CEA) are procedures that can restore patency and reduce the long-term risk of stroke. Both CAS and CEA have become common procedures in…

read more

Paediatric MS: What we know and what we still need to learn

5692 3201 Samyuktha Pillai, PhD

The landscape of paediatric multiple sclerosis (MS) is rapidly evolving. In her presentation titled ‘Pediatric MS – Current treatment strategies and future directions’ at the MS State of the Art…

read more

Multiple sclerosis management in the elderly

5692 3201 Samyuktha Pillai, PhD

The life expectancy in multiple sclerosis (MS) continues to increase and is now comparable to that of the general population.1 This increase comes with the challenge of learning how to…

read more

Preliminary results from stem cell transplantation as an MS therapy in Switzerland

5692 3201 Samyuktha Pillai, PhD

Autologous hematopoietic stem cell transplantation (aHSCT) has been used in the treatment of multiple sclerosis (MS) since 1995 and was approved in Switzerland in June 2018. In their presentation ‘Stem…

read more

MS 2022: Upcoming therapies, and their pros and cons

5692 3201 Samyuktha Pillai, PhD

The repertoire of available multiple sclerosis (MS) disease modifying therapies (DMTs) is constantly growing. In recent years, there have been several new DMTs that have entered the market. In his…

read more

Key pharmacological recommendations for hospitalised COVID‑19 patients: A German national treatment guidance

1500 1000 Noreen Hussain, PharmD

During the current coronavirus 2019 disease (COVID-19) pandemic, research is being developed and disseminated at an accelerated pace.1 The constant influx of data can be of varying quality and reliability…

read more

Cognitive deficits related to COVID-19: The challenge of measuring association

2560 1707 Akshar Patel

There has been increasing worry about possible cognitive consequences related to COVID-19 and recent case studies have revealed neurological problems in severely affected patients.1 Growing evidence shows that certain individuals…

read more

What are the implications for the third COVID-19 vaccine on CD-20-depleted people with MS – Oliver Findling reports

1500 1001 Shawn Haigh

In a guest post on “The MS Blog,” Dr Oliver Findling summarised a recent study on which he was the principal investigator: Humoral Immune Response after the Third SARS-CoV-2 mRNA…

read more

Speaking to Prof. Mary Reilly – “Complex cases are part of the attraction“

1300 1329 Anna Stelling, PhD

Prof. Mary Reilly is a consultant neurologist at the National Hospital for Neurology and Neurosurgery and a professor of clinical neurology, heading the division of clinical neurology in the Institute…

read more

Long-term survival of participants in the CENTAUR trial of sodium phenylbutyrate-taurursodiol in amyotrophic lateral sclerosis

960 640 Brainwork

The CENTAUR phase 2, randomised, placebo-controlled trial included patients with amyotrophic lateral sclerosis (ALS) who received a fixed dose formulation of sodium phenylbutyrate-taurursodiol (PB-TURSO). The trial showed results of a…

read more
Brainwork is supported by unrestricted grants from: